(Q28571978)

31 January 2017

title

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats (English)

1 reference

31 January 2017

1 reference

David A. Brenner

20

0 references

author name string

Christopher J. Parsons

1

1 reference

31 January 2017

Blair U. Bradford

2

1 reference

31 January 2017

Clark Q. Pan

3

1 reference

31 January 2017

Ellen Cheung

4

1 reference

31 January 2017

Michael Schauer

5

1 reference

31 January 2017

Andreas Knorr

6

1 reference

31 January 2017

Barbara Krebs

7

1 reference

31 January 2017

Sabine Kraft

8

1 reference

31 January 2017

Stefan Zahn

9

1 reference

31 January 2017

Bodo Brocks

10

1 reference

31 January 2017

Nikki Feirt

11

1 reference

31 January 2017

Baisong Mei

12

1 reference

31 January 2017

Myung-Sam Cho

13

1 reference

31 January 2017

Roopa Ramamoorthi

14

1 reference

31 January 2017

Greg Roldan

15

1 reference

31 January 2017

Paul Ng

16

1 reference

31 January 2017

Peggy Lum

17

1 reference

31 January 2017

Claudia Hirth-Dietrich

18

1 reference

31 January 2017

Adrian Tomkinson

19

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

31 January 2017

1 reference

31 January 2017

volume

40

1 reference

31 January 2017

issue

5

1 reference

31 January 2017

page(s)

1106–1115

1 reference

New aspects of hepatic fibrosis

31 January 2017

cites work

1 reference

7 January 2021

Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells

1 reference

7 January 2021

Activation of hepatic stellate cells--a key issue in liver fibrosis

1 reference

7 January 2021

Extracellular matrix degradation and the role of hepatic stellate cells

1 reference

7 January 2021

Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.

1 reference

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

7 January 2021

Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications.

1 reference

7 January 2021

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

1 reference

7 January 2021

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

1 reference

7 January 2021

Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat

1 reference

7 January 2021

Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats

1 reference

7 January 2021

Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis

1 reference

7 January 2021

Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

1 reference

7 January 2021

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

1 reference

7 January 2021

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

1 reference

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

7 January 2021

Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine

1 reference

7 January 2021

The role of Smad3 in mediating mouse hepatic stellate cell activation

1 reference

7 January 2021

Monitoring of collagen and collagen fragments in chromatography of protein mixtures

1 reference

7 January 2021

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

1 reference

7 January 2021

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

7 January 2021

Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.

1 reference

7 January 2021

Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration

1 reference

7 January 2021

Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats

1 reference

7 January 2021

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

1 reference

7 January 2021

Hepatic stellate cell behavior during resolution of liver injury

1 reference

7 January 2021

Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis

1 reference

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats

1 reference

7 January 2021

Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells

1 reference

7 January 2021

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor

1 reference

7 January 2021

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

1 reference

7 January 2021

Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid

1 reference

7 January 2021

Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice.

1 reference

7 January 2021

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

1 reference

7 January 2021

Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1

1 reference

7 January 2021

Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy

1 reference

7 January 2021

Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1

1 reference

7 January 2021

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver

1 reference

7 January 2021

Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell

1 reference

7 January 2021

Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

7 January 2021

Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat

1 reference

7 January 2021

Inhibition of rat liver fibrogenesis through noradrenergic antagonism

1 reference

7 January 2021

Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats

1 reference

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

7 January 2021